Focus: IQVIA is a global Contract Research Organization (CRO) and data analytics firm with 93,000 employees headquartered in Durham, NC. The company operates across clinical trials, regulatory services, and real-world intelligence with $15.0B in FY 2025 revenue.
Profile data last refreshed 11h ago · AI intelligence enriched 1w ago
No open roles listed right now. Follow IQVIA to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from IQVIA's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Help build intelligence for IQVIA
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
8-K Filing: Amanat Acquisition Corp. (AMAN) (CIK 0002112457) — INVESTOR PRESENTATION, DATED OCTOBER 2026
INVESTOR PRESENTATION, DATED OCTOBER 2026
8-K Filing: TCGX Acquisition Corp. (TCGX) (CIK 0002137965) — EX-99.2
EX-99.2
8-K Filing: FRACTYL HEALTH, INC. (GUTS) (CIK 0001572616) — EX-99.2
EX-99.2
8-K Filing: Biomea Fusion, Inc. (BMEA) (CIK 0001840439) — EX-99.1
EX-99.1
IQVIA Selects Veeva for Clinical Operations Applications - Contract Pharma
IQVIA Selects Veeva for Clinical Operations Applications Contract Pharma
IQVIA's Raja Shankar: AI Models Could Double Drug Trial Success Rates, But Can't Make Uncertainty Disappear - BigGo Finance
IQVIA's Raja Shankar: AI Models Could Double Drug Trial Success Rates, But Can't Make Uncertainty Disappear BigGo Finance
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Adult patient and caregiver perspectives on the impact of NF1-PN: Insights from a US qualitative survey.
Clinical, economic, and health-related quality of life impact of intrapartum group B Streptococcus (GBS) tests for prevention of neonatal GBS infection: a systematic literature review.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo